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Calcium-dependent secretion in digitonin-permeabilized adrenal chromaffin cells is stimulated by exogenous annexin II and 14-3-3 proteins. These 
proteins share a conserved domain that has been suggested to be involved in specific proten-protem interactions. We examined whether this domain 
was involved m secretion by using a synthetic peptide (P16) of sequence KGDYQKALLYLCGGDD corresponding to the C-terminus of annexin 
II. P16, but not truncated peptides. prevented the stimulation of secretion by 14-3-3 proteins and produced a partial inhibition of control secretion. 
These data suggest that the shared annexin/14-3-3 domain is important m the mechanisms controlling Cal+-dependent secretion and may play a 
key role m proteinprotem interactions durmg exocytosis. 
Exocytosis: Calcium: Secretion; Annexin; 14-3-3 Protein; Chromaffin cell 
1. INTRODUCTION 
Calcium-dependent exocytosis is likely to involve a 
number of specific proteins but we have only limited 
information on the possible proteins involved [1,2]. 
Soluble proteins (cytosolic and extrinsic membrane pro- 
teins) appear to be required for Ca”-dependent exocy- 
tosis [3], and a number of proteins that regulate exocy- 
tosis in permeabilized cells have been identified recently 
using assays based on recovery of secretory run-down 
following protein leakage after cell permeabilization. 
These proteins include annexin II [4.5], 14-3-3 proteins 
(Exol; [668]), ~145 [9,10] and several uncharacterised 
activities [6,11]. Annexin II, 14-3-3 proteins (Exol) and 
~145 possess properties that suggest that they play key 
roles in the regulation of the exocytotic response but 
their exact site of action remains to be determined. The 
14-3-3 protein family have a conserved internal domain 
which has homology to the C-terminus of the annexins 
[12]. The possession of this domain by both classes of 
proteins that stimulate exocytosis in permeabilized ad- 
renal chromaffin cells suggests that it could be involved 
in protein-protein interactions in exocytosis. In support 
of the idea that this domain mediates such interactions, 
it was found that a synthetic peptide corresponding to 
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the C-terminus of annexin I inhibited protein kinase C 
(PKC) binding to cytoskeletal protein receptors known 
as the RACKS (receptors for activated C kinase; 
[13,14]). In addition, the cytoplasmic domain of the 
synaptic vesicle protein, ~65 [15], binds to the RACKS 
and its binding was also inhibited by the synthetic pep- 
tide [16]. Recently, it has been suggested that ~65 (syn- 
aptotagmin) may be involved in exocytosis by docking 
secretory vesicles to the plasma membrane [17-191. In 
the light of these observations we have tested whether 
the conserved domain in annexins and 14-3-3 proteins 
is important for the stimulation of exocytosis in dig- 
itonin-permeabilized chromaffin cells. 
2. MATERIALS AND METHODS 
The synthetic peptides, P4. P9 and P16 (Fig. 1). were synthesised by 
Multiple Peptide Systems, San Diego, CA. and analysed by mass 
spectroscopy to confirm their molecular mass. Peptide purification 
was by reverse-phase HPLC. A second batch of P16 was synthesised 
m the Department of Biochemistry, University of Liverpool, and pep- 
tide purification carried out by ion-exchange chromatography on an 
FPLC Mono Q column (Pharmacia). All peptide solutions were 
freshly prepared and used the same day. Exol (sheep brain 14-3-3 
proteins) was purified and dialysed for use as previously described 
[6,7]. 
For cell permeabilization and catecholamme release, dissociated 
bovine adrenal medullary chromaffin cells were maintamed in culture 
for 337 days in 24-well trays as described previously [6.7]. For dig- 
itonin-perrneabilization [20.21], a variety of protocols were used and 
defined in the text but m general the cells were washed, permeabilized 
m buffer A (139 mM potassium glutamate. 2 mM ATP. 2 mM MgCl,, 
5 mM EGTA. 20 mM PIPES, pH 6.5) contaming20pM digitonin and 
incubated further in buffer A prior to challenge by replacement of 
buffer with fresh buffer A either without Ca” or with CaClz added 
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to a free Ca” concentration of 10 PM After lo-20 mm. buffer was 
removed, centrifuged at 16.000 x g for 2 min and aliquots assayed 
fluorlmetrically for released endogenous catecholamine [22]. Total 
catecholamine left in the cells was determmed by releasmg it with 1 ?Z 
Tnton X-100. Data for catecholamine release was expressed as a 
percentage of total cellular catecholamme. Data was calculated as 
mean ? S.E.M., but in some cases errors mere smaller than the sym- 
bols used and are not shown in the figures All experiments were 
carried out at 22- 25°C 
3. RESULTS 
Fig. 1 shows the conserved domain in 14-3-3 proteins 
showing sequence homology to the C-terminal domain 
of the annexins [12.23] and the three peptides, P4, P9 
and P16. used in this study. The sequence of the 16-mer 
was based on the C-terminus of annexin II. The effect 
of P16 on control secretion and secretion stimulated by 
Exol (brain 14-3-3 proteins) in digitonin-permeabilized 
chromaffin cells was first examined. As shown in Fig. 
2, P16 at 60 ,uM produced a partial inhibition of control 
secretion and abolished the stimulation due to a low (5 
PM) concentration of Exol. In the experiment shown 
P16 was absent during the stimulation period. In an 
attempt to increase the efficiency of the inhibition of 
secretion by P16 it was included in both pre-incubation 
and stimulation steps and the effects of a range of con- 
centrations of the peptide examined. Under these condi- 
tions P16 never produced more than a partial inhibition 
of secretion which was essentially maximal at 100 ,HM 
(Fig. 3A). From a series of experiments the maximal 
inhibition at 250 or 500 PM of P16 was 39.0 ? 4.1% 
(11 = 14). Also shown in Fig. 3 is that P4 did not inhibit 
secretion at any concentration. Instead. both P4 and P9 
produced a small but reproducible increase in catechol- 
amine secretion at 10 ,uM Ca”. The inhibition of secre- 
tion observed appeared, therefore, to be specific for the 
longer peptide. None of the peptides had any effect on 
Fig. 2. Peptide P16 inhibits control secretion and that stimulated by 
14-3-3 proteins (Exol). Chromaffin cells were permeabilized with 20 
,uM dlgltonin for 10 mm. pre-incubated for a further 15 mm hith or 
without peptlde (60 ,uM) or Exol (brain 14-3-3 proteins; 5 PM) and 
then challenged wnh 10 ,uM Ca” m the absence of any addltlons. The 
catecholamine release over a 20 min period was expressed as a percent- 
age of total cellular catecholamme (n = 4) The submaximal dose of 
Exol used produced a 20% increase m secretion (P < 0.001) which &as 
catecholamine secretion in the absence of Ca’+ (Fig. 
3B). Inhibition of secretion was found with two inde- 
pendently synthesised batches of P16 and with purifica- 
tion using two different techniques. 
P16 would be expected to inhibit processes involving 
annexin II or Exol. A proportion of these proteins leak 
from digitonin-permeabilized cells over a 25 min perme- 
abilization period [8,34,25]. Therefore, we examined the 
possibility that the degree of inhibition by P16 may have 
been higher with shorter pre-permeabilization periods. 
Using a high concentration of p16 and a range of proto- 
cols with no pre-permeabilization (Fig. 4, condition A) 
to pre-permeabilization for 25 min prior to stimulation 
(Fig. 4, condition D), it was found that the percentage 
inhibition by P16 was essentially the same (around 35- 
45%) in all cases (Fig. 4). 
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Fig. 1. Comparison of the common conserved domain in 14-3-3 pro- 
teins and annexm II and sequences of the synthetic peptides used 
Sequence\ are derived from thevarious known 14-3-3 proteins [33] and 
correspond to residues 127-142 of the eta form. The extreme C- 
terminal residues. 333-338. of annexm II and the 16-mer. 9-mer and 
4-mer synthetic peptldes used m this study are shown below. ldentlcal 
ammo aads are boxed and conservative substltutlons marked by as- 
terisks 
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It has been shown that secretion in permeabilized 
chromaffin cells can be dissected into distinct ATP-de- 
pendent and ATP-independent phases [26]. The degree 
of inhibition of secretion by P16 was found to be the 
same when cells were stimulated in the presence or ab- 
sence of ATP (33.3 and 39.0%. respectively. means from 
two separate experiments) indicating that the partial 
nature of the inhibition by P16 was not due to a selective 
action on one or other of these phases. The inhibition 
by P16 was independent of PKC activity as it was also 
detected when cells were incubated in the presence of a 
high (10 PM) concentration of the PKC inhibitor stau- 
rosporine. The inhibition of secretion by P16 was not 
due to a change in the Ca” affinity for secretion and 
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was not overcome by increasing Ca” concentration 
(not shown). 
4. DISCUSSION 
The results presented here show that a 16-mer syn- 
thetic peptide based on the C-terminus of annexin II 
and covering a domain conserved in annexins and 14-3- 
3 proteins partially inhibits Ca”-dependent secretion in 
digitonin permeabilized chromaffin cells. The effect ap- 
pears to be specific since truncated peptides had no 
inhibitory activity. This may be due to a lack of the 
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Fig. 3. P16 produces a specific inhibition of Ca”-dependent secretton. 
Chromaffin cells were permeabtlized with 20 ,uM digitonm for 10 min. 
pre-incubated for a further 5 mm with or without the indicated con- 
centration of peptide and then challenged with 0 ,uM or 10 PM Ca” 
in the presence of peptide The cdtecholamme released over a 10 min 
period was expressed as a percentage of total cellular catecholamine 
(n = 4). (A) Response to varying concentrations of P4 and P16. (B) 
Effect of P4. P9 and P16 at 500 PM on secretion at 0 and 10 PM Ca’+ 
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Fig. 4. P16 results in partial inhibition of secretion over a range of 
pre-penneabthzation times. (A) Cells were permeabtlized directly into 
10 PM Ca” f P16 and secretion measured after a 10 mm period. (B) 
Cells were permeabilized m 0 Ca” for 10 min k P16 and then chal- 
lenged in 10 PM Ca” k P16 and secretion measured after a further 
10 min. (C) Cells were permeabtlized m 0 Ca*’ for 10 min. pre-incu- 
bated for a further 5 min k peptide and then challenged for 10 mm in 
10 ,uM Ca” f peptide. (D) Cells were permeabilized in 0 Ca” for 10 
mm. pre-incubated for a further 15 mm + peptide and then challenged 
for 10 min m 10 PM Ca” k peptide. In each case ?I = 4. Increasmg 
permeabilization times prior to challenge leads to a decrease in the 
extent of secretion (secretory run-down), and P16 (500,~M) was inhib- 
itory at all times of pre-permeabilization. 
correct sequence required in the shorter peptides or the 
inability of these peptides to fold correctly. In previous 
work we found that a synthetic peptide based on the 
N-terminus of annexin II had no effect on secretion [27], 
whereas a peptide (annexin consensus peptide) based on 
a conserved region within the annexin repeats also par- 
tially inhibited Ca’+-dependent secretion in permeabil- 
ized chromaffin cells [4]. We have demonstrated that, 
following permeabilization and secretory run-down, ex- 
ogenous annexin II or 14-3-3 proteins are able to stim- 
ulate secretion from chromaffin cells [4,6]. The results 
from the use of synthetic peptides which inhibit control 
secretion support a role for endogenous annexin and/or 
14-3-3 proteins in secretion in chromaffin cells. The 
relative contribution of each of these classes of proteins 
cannot, however, be determined from this approach. 
The inhibitory effect of P16 on 14-3-3 protein-stimu- 
lated and on control secretion demonstrates a key role 
for this sequence in the events leading to exocytosis. 
Previous work has suggested that this domain may be 
involved in interactions between protein kinase C [14] 
or p65 [16] and a series of binding proteins known as 
RACKS. Amongst proteins that can act as RACKS are 
annexins I and II [13], and evidence that annexin V can 
inhibit PKC [28] and certain 14-3-3 proteins can inhibit 
[29] or stimulate [30] PKC suggests that they may also 
directly bind to PKC. The interaction of RACKS with 
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both PKC and p65 suggests that this may occur via the 
PKC C2 domain, which is also present in the cytoplas- 
mic fragment of p65 [31]. PKC C2 domains are also 
present in other proteins that translocate to the plasma 
membrane on cell stimulation, including phospholipase 
Cy [32], a cytosolic phospholipase A, [33] and GTPase 
activating protein [34]. It is possible that the common 
annexin/14-3-3 domain could be involved in a variety of 
specific protein-protein interactions, the consequence 
of which could be determined by the specificity of the 
annexin or 14-3-3 protein involved. It may be significant 
that the C-terminal domain in the annexins forms an 
exposed a-helical structure [35]. 
The finding that P16 produced no more than a partial 
inhibition of secretion under a variety of experimental 
conditions could be taken as suggesting that the an- 
nexin/14-3-3 proteins are not essential for exocytosis but 
merely regulate its extent. Alternatively. it is possible 
that assembly of a fusion complex involving these pro- 
teins is required for exocytosis, in which case any pre- 
formed complexes may not be inhibitable by the pep- 
tide. It is also possible that there are two parallel path- 
ways leading to exocytosis, only one of which involves 
annexin/14-3-3 proteins. It is not clear which of these is 
the correct explanation. P16 was inhibitory even after 
permeabilisation for 25 min, during which time consid- 
erable leakage of annexin II and 14-3-3 proteins occurs 
[8.24.25]. The effect of P16 may have been exerted on 
residual annexin II since it is known that some annexin 
II is tightly associated in a Ca’+-independent manner 
with membranes, including chromaffin granule mem- 
branes [36], and the annexin consensus peptide also 
produced partial inhibition of secretion after this per- 
meabilisation time [4]. 
The stimulatory effect of 14-3-3 proteins on exocyto- 
sis in chromaffin cells is potentiated by PKC activation 
[6,7]. It is unlikely that the stimulatory effect of 14-3-3 
proteins on secretion is due to a direct interaction with 
PKC [7]. In addition, the inhibition by P16 does not 
appear to be mediated through an effect on PKC-re- 
lated processes since the peptide was inhibitory on se- 
cretion in the absence of ATP and in the presence of 
staurosporine where PKC activity would not occur. The 
availability of this inhibitory peptide should allow fur- 
ther investigation of the protein-protein interactions 
involving annexin II and 14-3-3 that lead to stimulation 
of Ca”-dependent secretion. 
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